Takeaway
- A population-based study from Ontario, Canada, finds that mRNA-1273’s COVID-19 vaccine is associated with higher rates of myocarditis or pericarditis than BNT162b2’s , especially among young men.
- A longer interdose interval of ≥56 days is associated with lower rates of pericarditis/myocarditis after both mRNA vaccines.
Why this matters
- Findings confirm and extend...
